Lisata Therapeutics, Kuva Labs extend merger offer start date to June 10

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA

0.00
  • Lisata Therapeutics’ merger deal with Kuva Labs was amended, shifting the tender offer launch to June 10 from June 1.
  • The outside date moved to July 17 from July 1, with an optional extension to Aug. 17 tied to a USD 1.5 million non-refundable fee.
  • Lisata agreed to waive claims tied to the delayed offer start, subject to the offer commencing on June 10.
  • Additional waivers require USD 150,000 due June 12 and USD 100,000 due June 26, covering a missed USD 250,000 interim operating payment.
  • Kuva Labs acknowledged it lacks committed financing, committing to seek alternatives if expected funding becomes unavailable.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-024560), on June 09, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.